Anti-human MSLN antibody and MSLN-targeting immune effector cell Grant US-11957717-B2 United States of America 16 Apr 2024
ANTIBODIES AGAINST MSLN AND METHODS OF USE THEREOF Application WO-2024039672-A2 World Intellectual Property Organisation (WIPO) 22 Feb 2024
GENETICALLY ENGINEERED B CELLS AND METHODS OF USE THEREOF Application WO-2023172694-A1 World Intellectual Property Organisation (WIPO) 14 Sep 2023
CELL-SURFACE RECEPTORS RESPONSIVE TO LOSS OF HETEROZYGOSITY Application EP-4010377-A4 European Patent Office 06 Sep 2023